黄芪辅助治疗伴糖尿病的精神分裂症患者对血糖水平影响(1)
DOI：10.16662/j.cnki.1674-0742.2019.35.184
[摘要] 目的 分析黄芪辅助治疗伴糖尿病的精神分裂症患者对血糖水平影响。方法 方便选取102例2017年12月—2019年2月在该院治疗的伴糖尿病的精神分裂癥患者，两组患者均给予抗精神病药物治疗，将其随机分为对照组和观察组，各51例。给对照组给予胰岛素控制血糖，给观察组患者在对照组的基础上再联合黄芪治疗，观察并比较两组患者治疗前后血清SOD、HOMA-IR、FBG、2 hPG、HbAlc等水平的变化情况。 结果 治疗后，观察组SOD、FBG、2 hPG、FINS、HOMA-IR等指标分别为(108.31±19.0)NU/mL、(6.88±0.98)mmol/L、(8.31±1.09)mmol/L、(8.27±1.18)mU/L、(0.43±0.06)，对照组分别为(88.21±12.88)NU/mL、(8.03±1.34)mmol/L、(11.26±1.36)mmol/L、(11.01±2.07)mU/L、(0.87±0.21)，与对照组相比较差异有统计学意义(t=9.267、3.314、3.016、3.009、3.004，P<0.05 )。HbAlc水平，观察组为(8.03±2.05)%，对照组为(8.96±1.87)%，两组差异无统计学意义(t=0.214，P>0.05)。 结论 黄芪辅助治疗伴糖尿病的精神分裂症患者，能够有效改善患者的机体功能，降低患者的血糖水平，效果显著，有较高的推广价值。
[关键词] 黄芪;伴糖尿病的精神分裂症;血糖水平
[中图分类号] R749.3;R587.1 [文献标识码] A [文章编号] 1674-0742(2019)12(b)-0184-03
Effect of Astragalus Membranaceus on Blood Glucose Level in Patients with Schizophrenia with Diabetes
CHEN Kong-shu1， WU Zu-mei2
1.Ningde Rehabilitation Hospital， Men's Three Wards (Men's 3)， Ningde， Fujian Province， 352100 China;2.Department of Orthopaedics， 4th District， Ningde Hospital of Traditional Chinese Medicine， Ningde，Fujian Province， 352100 China
[Abstract] Objective To analyze the effect of astragalus on the treatment of blood glucose levels in patients with schizophrenia with diabetes. Methods Convenient selected a total of 102 patients with schizophrenia with diabetes mellitus who were treated in the hospital from December 2017 to February 2019 were enrolled. The patients in both groups were treated with antipsychotic drugs and randomly divided into control group and observation group. example. Insulin was administered to the control group to control blood glucose. The patients in the observation group were treated with jaundice on the basis of the control group. The changes of serum SOD， HOMA-IR， FBG， 2 hPG and HbAlc levels were observed and compared before and after treatment. Results After treatment， the indicators of SOD， FBG， 2 hPG， FINS and HOMA-IR in the observation group were (108.31±19.0) NU/mL， (6.88±0.98)mmol/L， (8.31±1.09)mmol/L， (8.27±1.18) mU/L， (0.43±0.06)， the control group were (88.21±12.88) NU/mL， (8.03±1.34)mmol/L， (11.26±1.36)mmol/L， (11.01±2.07)mU/L， (0.87±0.21) were statistically different from the control group(t=9.267， 3.314， 3.016， 3.009， 3.004， P<0.05). HbAlc level， observation group was (8.03±2.05)%， control The group was(8.96±1.87)%， there was no statistically significant difference between the two groups (t=0.214， P>0.05) . Conclusion Astragalus adjuvant treatment of patients with schizophrenia with diabetes can effectively improve the patient's body function. Reducing the patient's blood sugar level， the effect is significant， and has a high promotion value., http://www.100md.com(陈孔树，吴祖美)
[摘要] 目的 分析黄芪辅助治疗伴糖尿病的精神分裂症患者对血糖水平影响。方法 方便选取102例2017年12月—2019年2月在该院治疗的伴糖尿病的精神分裂癥患者，两组患者均给予抗精神病药物治疗，将其随机分为对照组和观察组，各51例。给对照组给予胰岛素控制血糖，给观察组患者在对照组的基础上再联合黄芪治疗，观察并比较两组患者治疗前后血清SOD、HOMA-IR、FBG、2 hPG、HbAlc等水平的变化情况。 结果 治疗后，观察组SOD、FBG、2 hPG、FINS、HOMA-IR等指标分别为(108.31±19.0)NU/mL、(6.88±0.98)mmol/L、(8.31±1.09)mmol/L、(8.27±1.18)mU/L、(0.43±0.06)，对照组分别为(88.21±12.88)NU/mL、(8.03±1.34)mmol/L、(11.26±1.36)mmol/L、(11.01±2.07)mU/L、(0.87±0.21)，与对照组相比较差异有统计学意义(t=9.267、3.314、3.016、3.009、3.004，P<0.05 )。HbAlc水平，观察组为(8.03±2.05)%，对照组为(8.96±1.87)%，两组差异无统计学意义(t=0.214，P>0.05)。 结论 黄芪辅助治疗伴糖尿病的精神分裂症患者，能够有效改善患者的机体功能，降低患者的血糖水平，效果显著，有较高的推广价值。
[关键词] 黄芪;伴糖尿病的精神分裂症;血糖水平
[中图分类号] R749.3;R587.1 [文献标识码] A [文章编号] 1674-0742(2019)12(b)-0184-03
Effect of Astragalus Membranaceus on Blood Glucose Level in Patients with Schizophrenia with Diabetes
CHEN Kong-shu1， WU Zu-mei2
1.Ningde Rehabilitation Hospital， Men's Three Wards (Men's 3)， Ningde， Fujian Province， 352100 China;2.Department of Orthopaedics， 4th District， Ningde Hospital of Traditional Chinese Medicine， Ningde，Fujian Province， 352100 China
[Abstract] Objective To analyze the effect of astragalus on the treatment of blood glucose levels in patients with schizophrenia with diabetes. Methods Convenient selected a total of 102 patients with schizophrenia with diabetes mellitus who were treated in the hospital from December 2017 to February 2019 were enrolled. The patients in both groups were treated with antipsychotic drugs and randomly divided into control group and observation group. example. Insulin was administered to the control group to control blood glucose. The patients in the observation group were treated with jaundice on the basis of the control group. The changes of serum SOD， HOMA-IR， FBG， 2 hPG and HbAlc levels were observed and compared before and after treatment. Results After treatment， the indicators of SOD， FBG， 2 hPG， FINS and HOMA-IR in the observation group were (108.31±19.0) NU/mL， (6.88±0.98)mmol/L， (8.31±1.09)mmol/L， (8.27±1.18) mU/L， (0.43±0.06)， the control group were (88.21±12.88) NU/mL， (8.03±1.34)mmol/L， (11.26±1.36)mmol/L， (11.01±2.07)mU/L， (0.87±0.21) were statistically different from the control group(t=9.267， 3.314， 3.016， 3.009， 3.004， P<0.05). HbAlc level， observation group was (8.03±2.05)%， control The group was(8.96±1.87)%， there was no statistically significant difference between the two groups (t=0.214， P>0.05) . Conclusion Astragalus adjuvant treatment of patients with schizophrenia with diabetes can effectively improve the patient's body function. Reducing the patient's blood sugar level， the effect is significant， and has a high promotion value., http://www.100md.com(陈孔树，吴祖美)